Syra Health Corp.
SYRA
$0.17
$0.0431.54%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 40.42% | -255.19% | 86.53% | 6.36% | -20.81% |
| Total Depreciation and Amortization | 103.89% | -476.43% | -74.51% | 168.83% | -251.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -72.66% | 650.88% | 159.38% | -112.70% | 4,481.82% |
| Change in Net Operating Assets | -301.56% | -24.72% | -106.12% | 157.87% | 491.92% |
| Cash from Operations | -18.38% | -236.97% | -145.83% | 173.68% | 48.05% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 14.81% | 24.15% | -44.03% | 10.77% | 14.91% |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 14.81% | 24.15% | -77.81% | 27.72% | -105.76% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.84% | -78.34% | -294.01% | 131.51% | -127.39% |